Hudson River Capital Partners LLC is a small-cap, private investment firm focused on the health and life sciences industry, both services and products. HRCP is located in Irvington, New York, 15 miles north of New York City. HRCP, through its investment entity Hudriv Investments LLC, was formed by James Foy and Clay Lifflander to invest in companies that add significant value to the health and life sciences systems and have the potential to be financially successful.
HRCP and its predecessors have invested over $900 million in 21 healthcare, life sciences and technology companies. The firm’s capital is proprietary and decision making is swift. In addition to investing capital, we seek to partner with our management teams and provide strategic advice and customer contacts whenever possible.
Today we have six portfolio companies – two of which, InquisitHealth and WellDoc, are in the area of diabetes management, Stirplate is a bioinformatics technology company, Q Drinks produces organic, high-end beverages, MedPilot is focused on medical billing and revenue management and Vytalize is a pioneer in telemedicine. InquisitHealth (2013 investment), Stirplate (2014) and MedPilot (2016) all participated in the highly successful Blueprint Health incubation program in Soho. We serve on the boards of InquisitHealth, Stirplate, Q Drinks and Vytalize.